热带医学杂志2024,Vol.24Issue(6) :876-878,888.DOI:10.3969/j.issn.1672-3619.2024.06.022

肥胖型2型糖尿病患者血清Glypican-4、Spexin及SFRP5表达水平及与胰岛素抵抗的关系

Expression of serum Glypican-4,Spexin and SFRP5 and their relationship with insulin resistance in obese type 2 diabetes patients

刘红景 刘辉 刘玉婷 胡英杰
热带医学杂志2024,Vol.24Issue(6) :876-878,888.DOI:10.3969/j.issn.1672-3619.2024.06.022

肥胖型2型糖尿病患者血清Glypican-4、Spexin及SFRP5表达水平及与胰岛素抵抗的关系

Expression of serum Glypican-4,Spexin and SFRP5 and their relationship with insulin resistance in obese type 2 diabetes patients

刘红景 1刘辉 1刘玉婷 1胡英杰2
扫码查看

作者信息

  • 1. 安徽省皖南康复医院(芜湖市第五人民医院)内分泌科,安徽芜湖 241000
  • 2. 上海市胸科医院肺部肿瘤临床医学中心特12病区,上海 200050
  • 折叠

摘要

目的 探讨肥胖型2型糖尿病患者血清脂肪因子(Glypican-4)、人神经肽(Spexin)及分泌型卷曲蛋白5(SFRP5)表达水平,并分析其与胰岛素抵抗的关系.方法 选择2020年5月-2022年5月安徽省皖南康复医院接诊的45例肥胖型2型糖尿病患者为病例组,并选择同期于本院体检体重健康的2型糖尿病40例作为对照组,比较两组血清Glypican-4、Spexin、SFRP5、胰岛素相关指标[空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)]水平,Spearman相关性分析Glypican-4、Spexin、SFRP5水平与FINS、HOMA-IR的相关性.结果 病例组血清Glypican-4、FINS、HOMA-IR 水平[(1.04±0.41)ng/mL、(15.78±3.14)mU/L、(3.82±1.05)]显著高于对照组[(0.81±0.25)ng/mL、(11.30±3.51)mU/L、(2.42±1.12)],Spexin、SFRP5 水平[(870.25±168.47)ng/L、(38.31±15.05)µg/L]显著低于对照组[(1 553.08±287.98)ng/L、(48.89±13.58)µg/L],差异均有统计学意义(t=3.075、6.212、5.946、13.520、3.386,P 均<0.05).相关性分析结果显示,血清 FINS、HOMA-IR 与 Glypican-4均成正相关(r=0.458、0.502,P均<0.05),与 Spexin、SFRP5均成负相关(r=-0.385、-0.416,-0.408、-0.496,P均<0.05).结论 肥胖型2型糖尿病患者血清Glypican-4、Spexin及SFRP5水平与胰岛素抵抗之间关系密切.

Abstract

Objective To study the expression of serum adipokine(Glypican-4),human neuropeptide(Spexin)and secreted frizzin related protein 5(SFRP5)and their relationship with insulin resistance in obese type 2 diabetes patients.Methods A total of 45 obese patients with type 2 diabetes admitted to Wannan Rehabilitation Hospital of Anhui Province from May 2020 to May 2022 were selected as the case group,and 40 patients with type 2 diabetes with healthy body weight in the same hospital were selected as the control group.Compare the changes of serum Glypican-4,Spexin,SFRP5,insulin related indicators[fasting insulin(FINS),insulin resistance index(HOMA-IR)]and Spearman correlation was used to analyze the correlation between Glypican-4,Spexin,SFRP5 levels and FINS,HOM-IR.Results Serum Glypican-4,FINS and HOMA-IR levels in case group[(1.04±0.41)ng/mL,(15.78±3.14)mU/L,(3.82±1.05)]were significantly higher than those in control group[(0.81±0.25)ng/mL,(11.30±3.51)mU/L,(2.42±1.12)];the levels of Spexin and SFRP5[(870.25±168.47)ng/L,(38.31±15.05)μg/L]were significantly lower than those of control group[(1 553.08±287.98)ng/L,(48.89±13.58)μg/L];the differences were statistically significant(t=3.075,6.212,5.946,13.520,3.386;all P<0.05).Correlation analysis results showed that serum FINS and HOMA-IR were positively correlated with Glypican-4(r=0.458,0.502;both P<0.05),and negatively correlated with Spexin and SFRP5(r=-0.385,-0.416;-0.408,-0.496;all P<0.05).Conclusion The expression of serum Glypican-4,Spexin and SFRP5 were closely related to insulin resistance in obese patients with type 2 diabetes.

关键词

肥胖型/2型糖尿病/脂肪因子/人神经肽/分泌型卷曲蛋白5/胰岛素抵抗

Key words

Obese type/Type 2 diabetes/Lipofactor/Human neuropeptide/Secretory curl protein 5/Insulin resistance

引用本文复制引用

基金项目

上海青年工作研究课题(2022QYTLX10-7)

出版年

2024
热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
段落导航相关论文